Related Articles
First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors
Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer
Outpatient therapy with irinotecan and low-dose cisplatin for metastatic colorectal cancer resistant to 5-fluorouracil